Drug name - Xopenex Hfa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7256310 SUNOVION Levalbuterol salt
Oct, 2024

(1 year, 10 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8765153 SUNOVION Levalbuterol salt
Dec, 2023

(1 year, 2 days from now)

Drugs and Companies using LEVALBUTEROL TARTRATE ingredient

Market Authorisation Date: 11 March, 2005

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage
Strength Dosage Availability
EQ 0.045MG BASE/INH AEROSOL, METERED;INHALATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in